Pacira BioSciences, Inc. Working Capital to Net Assets Ratio
Pacira BioSciences, Inc. working capital to net assets ratio. Pacira BioSciences, Inc. (PCRX) has a Working Capital to Net Assets ratio of 73.4% as of June 2026. Working capital of $493.20 Million (current assets of $615.22 Million minus current liabilities of $122.01 Million) is measured against net assets of $671.97 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Pacira BioSciences, Inc. (2008–2025)
Working capital to net assets ratio of Pacira BioSciences, Inc. from 2008 to 2025. This chart shows how Pacira BioSciences, Inc.'s Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the ratio stands at 73.4%, reflecting working capital of $493.20 Million against net assets of $671.97 Million USD. Explore how much of Pacira BioSciences, Inc.'s assets are long-term investments to see how much of total assets are deployed in long-term investments.
Pacira BioSciences, Inc. Working Capital to Net Assets Ratio by Year (2008–2025)
Pacira BioSciences, Inc. working capital to net assets ratio by year from 2008 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Pacira BioSciences, Inc. from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Pacira BioSciences, Inc. (PCRX) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 61.7% | $427.38 Million | $693.11 Million | $547.97 Million | $120.59 Million | ▲ +5.7 pp |
| 2024 | 55.9% | $435.21 Million | $778.35 Million | $745.13 Million | $309.92 Million | ▲ +8.5 pp |
| 2023 | 47.4% | $412.61 Million | $870.13 Million | $509.99 Million | $97.38 Million | ▲ +2.2 pp |
| 2022 | 45.2% | $350.56 Million | $775.01 Million | $498.33 Million | $147.77 Million | ▼ -2.0 pp |
| 2021 | 47.2% | $344.93 Million | $730.41 Million | $866.05 Million | $521.12 Million | ▼ -17.0 pp |
| 2020 | 64.3% | $398.30 Million | $619.69 Million | $651.62 Million | $253.33 Million | ▼ -20.5 pp |
| 2019 | 84.8% | $300.88 Million | $354.94 Million | $408.56 Million | $107.67 Million | ▼ -45.1 pp |
| 2018 | 129.9% | $417.31 Million | $321.23 Million | $477.97 Million | $60.66 Million | ▲ +10.1 pp |
| 2017 | 119.8% | $334.89 Million | $279.48 Million | $391.11 Million | $56.22 Million | ▲ +29.3 pp |
| 2016 | 90.5% | $198.25 Million | $218.98 Million | $243.09 Million | $44.84 Million | ▲ +44.3 pp |
| 2015 | 46.2% | $100.91 Million | $218.39 Million | $252.58 Million | $151.68 Million | ▲ +2.8 pp |
| 2014 | 43.4% | $74.25 Million | $171.15 Million | $214.26 Million | $140.01 Million | ▲ +80.2 pp |
| 2013 | -36.8% | $-15.19 Million | $41.25 Million | $106.75 Million | $121.94 Million | ▼ -107.8 pp |
| 2012 | 71.0% | $46.77 Million | $65.86 Million | $60.92 Million | $14.16 Million | ▼ -34.1 pp |
| 2011 | 105.1% | $50.74 Million | $48.27 Million | $82.65 Million | $31.91 Million | ▲ +135.6 pp |
| 2010 | -30.5% | $14.73 Million | $-48.38 Million | $31.05 Million | $16.32 Million | ▼ -38.6 pp |
| 2009 | 8.1% | $-1.87 Million | $-22.95 Million | $12.55 Million | $14.42 Million | ▼ -23.1 pp |
| 2008 | 31.3% | $2.34 Million | $7.49 Million | $19.36 Million | $17.02 Million | — |